Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 9/1/17 → 7/9/18 |
Phase 3b, Randomized, Double-blind, Placebocontrolled, Parallel Group Study to Assess the Safety, Efficacy, and Tolerability of Tezacaftor/Ivacaftor (TEZ/IVA) in an Orkambiexperienced Population Who Are Homozygous for the F508del-CFTR Mutation
- Pancham, Krishna (PI)